MarketPulse
M

$MEDP

27 articles found
0 positive
26 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misstatements on Financial Metrics

$MEDP faces class action lawsuit alleging executives misrepresented book-to-bill ratio; investors must act by June 5, 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Medpace Hit With Securities Class Action Over Backlog Cancellation Disclosures

Rosen Law Firm urges $MEDP investors to join class action alleging false statements about backlog cancellations between April 2025 and February 2026.
MEDPsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

MEDP Stock Plunges 15.9% on Guidance Misstatement; Securities Fraud Lawsuit Filed

Medpace Holdings faces securities lawsuit over allegedly inflated Q4 2025 guidance. Stock dropped 15.9% after actual book-to-bill ratio fell short of management projections.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Medpace Faces Class Action Over Alleged Misleading Statements; Deadline Looms

Clinical research firm Medpace faces class action lawsuit alleging misleading statements; investors must apply by June 5, 2026 to join the suit.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Medpace Faces Securities Lawsuit Over Backlog Claims; June 8 Deadline Looms

Medpace faces securities lawsuit alleging false backlog statements. Investors have until June 8, 2026 to join class action claiming overstated growth expectations.
MEDPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Allegedly Misleading Book-to-Bill Statements

Class action lawsuit filed against Medpace Holdings alleging executives made false statements about book-to-bill ratio from April 2025 to February 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Medpace Securities Lawsuit: Investors Urged to Join Class Action Over Backlog Misstatements

Rosen Law Firm solicits $MEDP investors for class action lawsuit alleging false statements about backlog cancellation rates between April 2025 and February 2026.
MEDPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Medpace Hit With Securities Class Action Over Backlog Claims

Rosen Law Firm recruits Medpace investors for class action alleging false backlog statements. Lead plaintiff deadline: June 8, 2026.
LUUPSTMEDPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Medpace Faces Class Action Over Alleged False Statements to Inflate Stock Price

Class action lawsuit filed against $MDPC alleges false statements inflated share price. Investors who bought stock between April 2025 and February 2026 may be eligible.
MEDPsecurities fraudclass action lawsuit
BenzingaBenzinga··Nabaparna Bhattacharya

Tech and Defense Stocks Lead Large-Cap Selloff as Earnings Disappointments Spark Rotation

Ten major large-cap stocks plummeted during April 20-24 week, led by Charter Communications' 24.78% decline amid earnings misses and analyst downgrades.
KTOSQXOQXOpBFCXLMT+6market declinelarge-cap stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Medpace Securities Lawsuit Alleges False Backlog Claims; June 8 Deadline Looms

Rosen Law Firm notifies $MEDP investors of securities class action over alleged misstatements regarding backlog cancellation rates between April 2025 and February 2026.
MEDPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Hit With Class Action Over Inflated Book-to-Bill Claims

Medpace faces class action lawsuit over allegedly inflated book-to-bill ratio claims during April 2025-February 2026 period; lead plaintiff deadline set for June 5, 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Securities Class Action Against Eos Energy; May 5 Deadline Looms

Rosen Law Firm files securities class action against Eos Energy Enterprises ($EOSE) alleging false statements. May 5, 2026 lead plaintiff deadline for affected investors.
EOSEMNDYMEDPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Law Offices Of Howard G. Smith

Four Public Companies Face Securities Fraud Class Actions; Investor Deadline Looms

Law Offices of Howard G. Smith initiates securities fraud class actions against $PINS, $NUAI, $GOSS, and $MEDP; investors have until May-June 2026 deadline for lead plaintiff motions.
PINSMEDPNUAINUAIWGOSSsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misleading Book-to-Bill Claims

Class action lawsuit filed against $MDPC alleging executives overstated book-to-bill ratio at approximately 1.15 despite contrary internal data from April 2025 to February 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Gross Law Firm

Medpace Hit With Securities Lawsuit Over Backlog Misstatements

Medpace faces class action suit alleging false guidance on cancellation rates. Stock plunged 15.9% after Q4 2025 miss, triggering investor claims.
MEDPstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Securities Class Action Against $MEDP Medpace Holdings

Rosen Law Firm files securities class action against Medpace Holdings for alleged false statements regarding business metrics and financial performance, urging investors to act before deadline.
VITLMNDYMEDPsecurities class actionlead plaintiff
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Medpace Stock Plunges 15.9% After Book-to-Bill Miss; Class Action Filed

Robbins LLP filed class action lawsuit against $MEDP for allegedly misleading investors about book-to-bill guidance, triggering 15.9% stock decline.
MEDPclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Medpace Stock Plunges 16% as Securities Lawsuit Alleges Guidance Misstatements

Robbins Geller files class action against $MEDP over alleged false book-to-bill projections. Stock fell 16% after Q4 miss. Lead plaintiff deadline: June 8, 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misstatements on Book-to-Bill Ratio

Class action lawsuit filed against $MDPC alleging executives made false statements about book-to-bill ratio from April 2025 to February 2026, claiming overstated business prospects.
MEDPsecurities fraudclass action lawsuit